News
AbbVie Inc. (NYSE:ABBV) has spotlighted major advancements in its oncology pipeline at the ASCO 2025 Annual Meeting, ...
AbbVie Inc. (NYSE:ABBV) and the Chicago Cubs have announced a major multi-year partnership to fight cancer, launching the ...
Berkshire Hathaway, AbbVie and Intuitive Surgical beat estimates as analysts highlight growth drivers, headwinds and ...
Shares of AbbVie Inc. ABBV rallied 1.34% to $185.72 Tuesday, on what proved to be an all-around positive trading session for ...
The stock's fall snapped a three-day winning streak.
North Chicago, Illinois-based AbbVie Inc. (ABBV) discovers, develops, manufactures, and sells pharmaceuticals worldwide. With ...
Zacks highlights strong showings from ABBV, ISRG, HBB and AXIL, while BRK.B gains on insurance growth and capital strength ...
We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best income stocks. Amid ...
Neuropeutics Inc receives a year of laboratory space and equipment at no cost, as well as access to support and mentorship "We are delighted to have this opportunity to collaborate with a global ...
Compared to the aggregate P/E ratio of 44.82 in the Biotechnology industry, AbbVie Inc. has a higher P/E ratio of 81.23. Shareholders might be inclined to think that AbbVie Inc. might perform ...
In its first-quarter 2025 investor letter, Carillon Eagle Growth & Income Fund highlighted stocks such as AbbVie Inc. (NYSE:ABBV). AbbVie Inc. (NYSE:ABBV) is a research-based biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results